年龄对左侧乳腺癌放疗中DIBH影响的前瞻性研究评估
该研究基于GATTUM和B-REST前瞻性试验数据,首先调查100例≥65岁女性乳腺癌患者对DIBH的态度和屏气能力,再通过配对分析比较≥65岁(n=30)与<65岁(n=30)患者在DIBH期间的呼吸和剂量学参数。结果显示两组在屏气幅度、持续时间和稳定性以及DIBH诱导的危及器官剂量降低方面均无显著差异,结论认为年龄本身不应作为排除DIBH的标准。
要点
- 98%的≥65岁患者认为年龄不应作为选择DIBH的标准,66%能屏气超过20秒。
- 配对分析显示≥65岁与<65岁患者在DIBH呼吸参数上无显著差异。
- 两组DIBH诱导的危及器官剂量降低无显著差异,年龄本身不应排除DIBH。
核心结论
- 基于本研究结果,年龄本身不应作为左侧乳腺癌放疗中排除DIBH的标准。
研究设计与样本
- 首先对100例≥65岁女性乳腺癌患者进行14项问卷调查,评估其对DIBH的态度和屏气能力。
- 其次利用GATTUM和B-REST前瞻性试验的汇总数据进行配对分析,比较≥65岁(n=30)与<65岁(n=30)患者DIBH期间的呼吸和剂量学参数。
主要发现
- 调查中98%的患者表示年龄不应作为选择DIBH的标准,66%的患者能屏气超过20秒。
- 配对分析显示≥65岁与<65岁患者在屏气幅度、持续时间和稳定性方面无显著差异。
- 两组在DIBH诱导的危及器官剂量降低方面也无显著差异。
临床怎么用
- 对于左侧乳腺癌术后放疗患者,不应仅因年龄≥65岁而排除DIBH技术。
- ≥65岁患者对DIBH兴趣高且多数具备足够屏气能力,可考虑纳入DIBH放疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adjuvant radiotherapy (RT) of left sided breast cancer is increasingly performed in deep inspiration breath hold (DIBH). This technique requires active involvement and compliance of patients as well as pulmonary endurance. Since previous studies focused on female patients with a median age under 65 years to test practicability of DIBH and advantages in comparison to free breathing (FB), DIBH in elderly patients over 65 years remains mostly underexplored. This study aims to evaluate attitudes and feasibility of DIBH in elderly breast cancer patients. METHODS: First a 14-item survey of 100 female breast cancer patients aged ≥65 years was conducted to assess their attitudes toward DIBH and their breath-hold capability. Secondly, we performed a matched-pair analyses using pooled data from the prospective GATTUM and B-REST trials to compare respiratory and dosimetric parameters during DIBH between patients aged ≥65 years (n = 30) and <65 years (n = 30). RESULTS: According to the survey large majority of patients were interested in DIBH: 98 % stated that age should not be a criterion when selecting patients for DIBH, and 66 were able to hold their breath > 20 s. Based on the matched-pair analyses of the GATTUM and B-Rest trials, no significant differences were observed regarding breath hold amplitude, duration and stability, and in DIBH-induced dose reduction to organs at risk between elderly (≥65) (n = 30) and younger patients (n = 30). CONCLUSION: Based on our results age alone should not be used as a criterion for excluding patients from DIBH in the treatment of left-sided breast cancer.
引用
- Moser R, Buchecker LM, Bohlen JM, et al. Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials. Clin Transl Radiat Oncol. 2025. PMID: 40612359. doi:10.1016/j.ctro.2025.100956
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。